Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Hyoscine butylbromide manufacturers

4 products found

Filters

Filters

Filters , active

Country of origin : Ecuador

Clear all

4 products found

hyoscine butylbromide + paracetamol

Tablets 10mg+500mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ecuador
GMP approvals
WHO
Manufacturer #18729
The company is focused to develop, manufacture and market high-quality pharmaceutical products, satisfying the needs of customers, and doctors and improving the quality of life of patients, supported by the high professional level of our human and technological resources, under strict quality controls and oriented to the preservation of the environment.

Manufacturer usually replies in 4 days

hyoscine butylbromide + ibuprofen

Capsules 20 mg + 400 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ecuador
GMP approvals
WHO
Manufacturer #18717
The quality Policy is based on meeting the requirements of customer satisfaction by providing pharmaceutical products for human and veterinary use of optimum quality. Complying with current legal norms and regulations in force. The company is committed to continuous improvement through an effective review of the processes, growth planning, developing new products, and fostering a renewed work environment.

paracetamol + hyoscine butylbromide

Oral drops 80mg+1mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ecuador
GMP approvals
WHO
Manufacturer #18729
The company is focused to develop, manufacture and market high-quality pharmaceutical products, satisfying the needs of customers, and doctors and improving the quality of life of patients, supported by the high professional level of our human and technological resources, under strict quality controls and oriented to the preservation of the environment.

Manufacturer usually replies in 4 days

homatropine methylbromide + hyoscine butylbromide + magnesium hydroxide

Tablets 3mg+4mg+500mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ecuador
GMP approvals
WHO
Manufacturer #18847
The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company produces a wide range of products with quality ingredients.

Hyoscine butylbromide

Hyoscine butylbromide, also called scopolamine butylbromide is a medication used in the treatment of Crampy abdominal pain, bladder & esophageal spasms & renal colic. It especially eases the bloating and the spasm-type pain associated with irritable bowel syndrome and diverticular disease. Its actions relax muscles in gastrointestinal and urinary systems. Hyoscine butylbromide also improves respiratory secretions at the end of life. It is also effective in decreasing the duration of the first stage of labor, while not being associated with any obvious adverse outcomes in mother or newborn. HB improves the quality of pictures during abdominal or pelvic MRI or CT. It can also help bladder cramps and period pain. Its medicine form is manufactured from Hyoscine, which occurs naturally in the plant deadly nightshade. Hyoscine butylbromide is sold under the brand name Buscopan among others. Hyoscine butylbromide has not received approved for sales in the United States, but a similar compound, Methscopolamine is used instead. In Europe, the Manufacturer and Licence Holder is Istituto De Angeli S.r.I, Loc. Prulli in Italy and procured from within the EU. The Licence Holder is LTT Pharma Limited from the UK. Forms and Dosage Hyoscine butylbromide is taken orally or given as an injection into a muscle, or into a vein, as a 20 mg in 1 ml ampoule for Intra Muscular or slow Intra Venous injection. In the treatment of MR enterography, the standard prescribed dose is 0.3 mg/kg IV with a maximum dose capped at 20 mg. in the treatment of Acute spasms, the oral medicine for children in the age group of 6-12 yrs old is 10 mg/dose and for 12-18 yrs old: 20 mg/dose. As an injection for either the muscle or nerves, the recommended dosage for children age 2-6 yrs old is 5 mg per dose with max capped at 15 mg per day. For children aged 6-12 years old it is 5-10 mg per dose with max capped at 30 mg per day and for teenagers, in the age group of 12-18 yrs old, the prescribed dose is 20 mg per dose, with max capped at 80 mg/day. For Adults, the standard recommended dose is 10-20 mg per dose up to 3-5 times a day with the maximum capped at 100 mg per day.

The cost of Hyoscine butylbromide

In the developing countries in India, a 2 weeks supply of tablet costs the consumer as low as USD2.3, whereas the injection cost USD1.5. in Australia, 5 ampoules of 20 mg injections cost AUD23.

How does Hyoscine butylbromide work?

Hyoscine butylbromide quaternary ammonium compound as well as a semisynthetic derivative of Scopolamine. As an Antimuscarinic, it binds to muscarinic acetylcholine receptors, blocking their effect. The attachment of the butyl-bromide moiety minimizes undesirable central nervous system side effects associated with scopolamine/Hyoscine, thereby effectively preventing the movement of this drug across the blood-brain barrier. It decreases the stimulation in smooth muscle contractions and the production of respiratory secretions.

Finding Hyoscine butylbromide Manufacturers and Suppliers:

The process of finding trusted Hyoscine butylbromide manufacturers and Hyoscine butylbromide suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Hyoscine butylbromide. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.